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Abstract
Background: The intrauterine environment is critical for fetal growth and development.
However, observational associations between maternal gestational lipid concentrations
and offspring birth weight (BW) have been inconsistent and ascertaining causality is
challenging.
Methods: We used a novel two-sample Mendelian randomization (MR) approach to esti-
mate the causal effect of maternal gestational high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglyceride concentrations on
offspring BW. Single nucleotide polymorphisms (SNPs) associated with serum HDL-C,
LDL-C and triglyceride concentrations identified in the Global Lipids Genetics
Consortium genome-wide association study meta-analysis (n¼ 188 577 European-
ancestry individuals; sample 1) were selected as instrumental variables. The effects of
these SNPs on offspring BW were estimated using a structural equation model in the UK
Biobank and Early Growth Genetics consortium (n¼230 069 European-ancestry individu-
als; sample 2) that enabled partitioning of the genetic associations into maternal- (intra-
uterine) and fetal-specific effects.
Results: We found no evidence for a causal effect of maternal gestational HDL-C, LDL-C
or triglyceride concentrations on offspring BW [standard deviation change in BW per
standard deviation higher in HDL-C ¼ 0.005 (95% confidence interval: 0.039, 0.029),
LDL-C¼0.014 (0.017, 0.045), and triglycerides ¼ 0.014 (0.025, 0.052)].
VC The Author(s) 2019. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
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Conclusions: Our findings suggest that maternal gestational HDL-C, LDL-C and triglycer-
ide concentrations play a limited role in determining offspring BW. However, we cannot
comment on the impact of these and other lipid fractions on fetal development more
generally. Our study illustrates the power and flexibility of two-sample MR in assessing
the causal effect of maternal environmental exposures on offspring outcomes.
Key words: Mendelian randomization, maternal effect, birth weight, high-density lipoprotein cholesterol, low-den-
sity lipoprotein cholesterol, triglycerides
Introduction
On average, babies born at term below the 25th percentile
or above the 85th percentile of the population distribution
for birth weight (BW) in high-income countries are at
higher risk of adverse perinatal outcomes, such as still-
birth, neonatal mortality, respiratory problems and the
need for admission to neonatal intensive care.1
Additionally, babies born of lower and higher BW are at
increased risk of adverse future health. For example, in-
verse associations have been identified between BW and
coronary heart disease,2 positive associations with body
mass index (BMI)3 and most cancers4 and U-shaped associ-
ations with future diabetes risk.5 Understanding which ma-
ternal traits during pregnancy causally affect offspring BW
will assist in understanding the mechanisms underlying
these associations and defining a healthy BW range.
Maternal serum lipid concentrations are one such trait
that could influence offspring BW. Observational studies
have reported inconsistent results regarding the relationship
between maternal lipid concentrations and offspring BW. For
example, maternal serum high-density lipoprotein cholesterol
(HDL-C) concentrations have been reported to have pos-
itive,6 negative,7–9 and no10–12 association with offspring
BW. In the case of maternal low-density lipoprotein choles-
terol (LDL-C), most studies have reported no association
with offspring BW7–10 although there is some evidence for a
negative association between smaller subclasses of LDL-C
and offspring BW.10 Higher maternal triglyceride concentra-
tions have been shown to be associated with higher offspring
BW;6,11,12 however, some associations were only observed
when the study samples were stratified by maternal pre-
pregnancy BMI (i.e. in mothers with pre-pregnancy BMI be-
tween 18.5 and 24.9 kg/m2 8,9 or overweight/obese mothers
with BMI>25 kg/m2).7 Bivariate linkage disequilibrium (LD)
score regression analyses13,14 applied to a large-scale ge-
nome-wide association study (GWAS) meta-analysis of BW
has shown negative genetic correlations of it with LDL-C and
triglyceride concentrations, and a positive genetic correlation
with HDL-C.15 However, it is unclear whether these genetic
correlations reflect pleiotropic effects of genetic loci influenc-
ing both traits or are a consequence of maternal blood lipids
causally affecting offspring BW.
Mendelian randomization (MR) is a method commonly
used in epidemiology to estimate the causal relationship
between a modifiable environmental exposure of interest
and a medically relevant trait or disease.16 It uses genetic
variants, most commonly single nucleotide polymorphisms
(SNPs), robustly associated with the modifiable environ-
mental exposure of interest as instrumental variables to es-
timate the causal effect. In the context of this manuscript,
the environmental exposures of primary interest are mater-
nal lipid concentrations during pregnancy (i.e. maternal
HDL-C, maternal LDL-C and maternal triglycerides) and
the medically relevant outcome is offspring BW.
Key Messages
• We used a novel two-sample Mendelian randomization design to investigate the causal effect of maternal gestational
lipid concentrations on offspring birth weight.
• We used summary statistics from genome-wide association studies that predict serum high-density lipoprotein cho-
lesterol, low-density lipoprotein cholesterol, and triglyceride concentrations and birth weight, with the latter being
partitioned into maternal- and fetal-specific effects.
• Our findings showed limited support for a causal effect of maternal gestational high-density lipoprotein cholesterol,
low-density lipoprotein cholesterol, and triglyceride concentrations on offspring birth weight.
• The same method could be used to examine other maternal exposures putatively causally related to offspring out-
comes assessed later in life.
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Unlike MR studies investigating the causal relationship
between two adult traits, estimating the causal effect of
maternal exposures on offspring outcomes using MR is dif-
ficult due to the fact that maternal (and paternal) genotype
determine offspring genotype. Specifically, any association
between maternal genotype and offspring outcome could
be mediated by the child’s genotype rather than through
the maternal genotype operating on the intrauterine envi-
ronment (Figure 1). To ensure an unbiased causal estimate
of the maternal environmental exposure on offspring out-
come, one could perform MR analyses in genotyped
mother–offspring duos and statistically correct for off-
spring’s genotype by conditioning on it.6,17 However, there
are only a small number of cohorts worldwide that have
genotyped mother–offspring duos, meaning that such anal-
yses may be underpowered, especially in comparison to
two-sample MR studies where different but maximized
samples of individuals report SNP–exposure and SNP–
outcome associations. Our previous MR study used geno-
typed mother–offspring duos in an attempt to examine the
effect of maternal obesity related traits, including HDL-C
and triglyceride concentrations, on offspring BW.6 Results
suggested a possible causal inverse effect of maternal
triglycerides on BW (i.e. opposite direction to most previ-
ous multivariable regression results). However, despite
bringing together as many studies with genotyped mater-
nal–offspring duos as possible in a sample size of 11 031
the effect was imprecisely estimated with wide confidence
intervals: difference in mean BW per 1-standard deviation
(SD) higher triglycerides ¼ 33 g [95% confidence inter-
vals (CIs): 86, 20].6 For HDL-C the results were more
clearly null [1 g (55, 54); n¼ 9176].
An alternative solution, which we adopt, is to employ
two-sample MR to estimate the causal effect of maternal
lipid concentrations on offspring BW, but using unbiased
estimates of the maternal genetic effect on BW from a
very large GWAS meta-analysis of the UK Biobank and
the Early Growth Genetics (EGG) Consortium.18
Recently, we showed how structural equation modelling
(SEM) could be used to partition genetic effects on BW
into maternal-specific and fetal-specific components in
the UK Biobank Study, even in the absence of genotyped
mother–offspring duos.19 Our design relies on the fact
that genotyped individuals in the UK Biobank reported
their own BW, and (in the case of women) the BW of their
first child. The SEM can also include summary statistics
from the EGG consortium GWAS of own or offspring
BW, increasing the sample size and therefore the precision
of the maternal- and fetal-specific genetic effect esti-
mates.19 Maternal genetic effects estimated using this
study design represent the association between maternal
genotype and offspring BW with the effect of child’s ge-
notype removed (i.e. similar to an analysis where child’s
genotype has been included as a covariate in a study of
genotyped mother–offspring duos, but in vastly larger
samples of individuals). Using a two-sample MR frame-
work, these estimates of the maternal genetic effect on
BW can subsequently be combined with SNP-exposure
estimates for the maternal exposures we are interested in,
allowing us to maximize sample size and statistical power
(Figure 2).
In a recent study using this novel two-sample MR ap-
proach, we demonstrated a positive causal effect of mater-
nal height and fasting glucose and inverse causal effect of
blood pressure on offspring BW18. In the present study we
used this two-sample MR design to investigate a possible
causal effect of maternal lipid concentrations on offspring
BW. We performed two-sample inverse variance weighted
MR, and also a series of sensitivity analyses including MR
Egger regression,20 weighted median21 and mode-based22
analyses, with SNP-lipid associations from the Global
Lipids Genetics Consortium23 and the maternal SNP-BW
associations from the UK Biobank and the EGG
Consortium.18
Figure 1. A directed acyclic graph (DAG) showing maternal and fetal ge-
netic effects on offspring birth weight. Offspring birth weight can be
influenced by both maternal and fetal genotypes, the former operating
through the intrauterine environment and via fetal genotype. As fetal
genotype is determined by maternal and paternal genotypes, to accu-
rately estimate the association between maternal genotype and off-
spring birth weight we need to partition the overall genetic effect into
maternal- and fetal-specific genetic components. This DAG shows the
key pathways and assumptions of our analyses. We have not depicted
the (unknown) paths through which fetal genotype would influence fe-
tal growth and birth weight. Note, also that we are assuming that phe-
notypes relating to fetal genotype do not affect the intrauterine
environment, whereas it is known that waste products form the fetus
are transferred back across the placenta into the maternal circulation. If
fetal genotype influences the production or transfer of waste products,
this assumption will be violated.
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Methods
Two-sample inverse variance weighted
Mendelian randomization analysis
To investigate the causal relationship between maternal lipid
concentrations and offspring BW we initially performed two-
sample inverse variance weighted (IVW) MR analyses24,25 us-
ing GWAS summary results data from the Global Lipids
Genetics Consortium (n¼ 188 577 European-ancestry indi-
viduals; sample 1)23 and the summary results data from the
GWAS meta-analysis of BW in the UK Biobank and the EGG
Consortium (n¼ 230 069 European-ancestry individuals;
sample 2).18 The magnitude of the causal effect (b^IVW) was
estimated as the average of the SNP-outcome effect
ðb^ZYðmatÞÞ divided by the SNP-exposure effect ðb^ZXÞ for all
SNPs associated with an exposure, and weighted by the in-
verse variance of the SNP-outcome effect ðb^ZYðmatÞÞ. The re-
gression slope (ratio) in IVW analyses is forced through a
zero intercept (i.e. assuming that there is no unbalanced hori-
zontal pleiotropy and hence a zero difference in exposure
results in zero difference in BW).
The exposure variables of interest were maternal con-
centrations of three serum lipid fractions: HDL-C, LDL-C
and triglycerides. A total of 185 independent SNPs have
previously been robustly associated with these three lipid
fractions (P< 5.0 x 10–8) and were selected as instrumental
variables (IVs) for MR analyses (Supplementary Table 1,
available as Supplementary data at IJE online). Of these
SNPs, 96 were associated with HDL-C, 82 were associated
with LDL-C, and 60 were associated with triglycerides, all
at the genome-wide significance level of P<5.0 x 10–8.
We refer to these SNPs as the ‘Unrestricted Set’ of SNPs for
each of the three serum lipids. As many of these SNPs were
associated with more than one lipid fraction, which poten-
tially violates the exclusion restriction assumption of IVW
MR analysis, we created a ‘Restricted Set’ of SNPs, which
had strong evidence of association with one lipid fraction
only (i.e. P< 5.0 x 10–8 for one lipid and P>0.05 for the
other two). This reduced the number of associated SNPs to
15 SNPs for HDL-C, 20 SNPs for LDL-C, and 3 SNPs for
triglycerides (Supplementary Table 1, available as
Supplementary data at IJE online). We did not perform
MR analyses using the ‘Restricted Set’ for triglycerides be-
cause the 3 SNPs together only accounted for <0.1% of
the phenotypic variance in serum triglyceride concentra-
tions and calculations indicated low power to detect a
causal relationship of maternal triglycerides on BW.
The outcome of interest was offspring BW. Because of
concerns regarding confounding due to the effect of mater-
nal genotypes on offspring genotypes, in our MR analyses
we used maternal-specific genetic effects on offspring BW
estimated using the SEM for each of the lipid-associated
SNPs, as illustrated in Figure 2. The maternal SNP effects
on BW estimated using the SEM are equivalent to the re-
gression of offspring BW on maternal genotype conditional
on offspring genotype. The maternal- (and fetal-) specific
effects on offspring BW for each of the genetic instruments
are presented in Supplementary Table 1, available as
Supplementary data at IJE online. We note that the SNP
effects on BW were obtained from a GWAS meta-analy-
sis18 and that BW was estimated in a variety of different
ways including by retrospective self-report in the UK
Figure 2. Two-sample Mendelian randomization testing the causal effect of maternal and fetal serum lipid concentrations on offspring birth weight.
Estimates of the SNP-lipid association (b^ZX) are calculated in sample 1. The association between these same SNPs and birth weight (BW) is then esti-
mated in sample 2, except in this case the genetic association is partitioned into maternal (b^ZYðmatÞ) and fetal (b^ZYðfetÞ) effects on BW. These estimates
are combined to yield estimates for each SNP of the maternal effect of serum lipid concentrations on offspring BW (b^XYðmatÞ ¼ b^ZYðmatÞb^ZX ), and the off-
spring effect of their own serum lipid concentrations on their own BW (b^XYðfetÞ ¼ b^ZYðfetÞb^ZX ). Finally, the estimates at each SNP are combined using the
two-sample MR approaches, including inverse-variance weighted analysis (b^IVW ) and the various sensitivity analyses, to produce an overall causal
estimate of serum lipids on BW.
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Biobank cohort. Where possible, studies in the EGG con-
sortium were adjusted for gestational age prior to GWAS
analysis; as gestational age is not recorded in UK Biobank
this adjustment was not possible.
To investigate the possibility of directional pleiotropy in
our data, we used funnel plots20 that plot instrument
strength against the causal estimates for all IVs, and sensi-
tivity analyses (see below) that relax some of the horizontal
pleiotropy assumptions. Asymmetry in funnel plots sug-
gests that causal estimates from weaker variants tend to be
skewed in one direction and may indicate directional hori-
zontal pleiotropy.
Sensitivity analyses
As the IVW approach could yield biased estimates in the
presence of horizontal pleiotropy (i.e. where some SNPs in-
fluence the outcome via additional paths other than via the
exposure), we performed four sensitivity analyses using ad-
ditional MR models, MR Egger regression,20 the weighted
median estimator,21 and the simple and weighted mode-
based estimator.22
MR Egger regression involves a weighted linear regres-
sion of b^ZYðMatÞ on b^ZX where the intercept from the re-
gression is free to vary. The slope of the regression
provides an estimate of the causal effect of the exposure on
the outcome that is free from directional horizontal pleiot-
ropy.20 The presence of an intercept that is different from
zero indicates overall directional pleiotropy, which would
bias the IVW estimate. As the assessment of directional
pleiotropy using MR Egger can be affected by the orienta-
tion of the IVs,26 we oriented the effect alleles of all IVs to
have positive effects on the exposure prior to all MR Egger
analyses. The validity of MR Egger regression relies on an
assumption known as the ‘InSIDE (INstrument Strength
Independent of Direct Effect) assumption’, which states
that the pleiotropic effects of SNPs must be independent of
their strength as instruments. In other words, the strength
of association between the SNPs and the outcome via path-
ways other than through the exposure must be independent
of the strength of the SNP-exposure associations. This is a
weaker assumption than requiring the complete absence of
horizontal pleiotropy to obtain valid causal estimates,
which is the assumption required in traditional IVW MR
analysis. However, although MR Egger regression provides
a more robust estimate of the causal effect of the exposure
on the outcome, its power to detect a causal effect is much
lower than IVW analyses.20 MR Egger regression also
makes the assumption that the SNP-exposure associations
are estimated without error. To check whether this
‘NOME (NO Measurement Error) assumption’ was vio-
lated in the two-sample MR Egger regression context, we
used the I2GX statistic
27 to estimate the potential relative (di-
lution) bias due to measurement error. The I2GX statistic is
a value ranging between 0 and 1, with the value close to 1
indicating that the SNP-exposure associations are suffi-
ciently heterogeneous and the uncertainty is relatively
small compared with its variability so the violation of
NOME is negligible.
The weighted median estimator approach uses the
weighted median of the ratios (i.e. the ratio of b^ZYðMatÞ and
b^ZX) of all the IVs, as opposed to the weighted mean that
is used in the IVW approach. The approach provides an as-
ymptotically consistent estimate of the causal effect and
tolerates up to (but not including) 50% of the weight com-
ing from invalid IVs (e.g. IVs that violate the exclusion re-
striction assumption).21
The simple mode-based estimator clusters the SNPs into
groups based on similarity of causal effect estimates.22 The
causal effect is estimated based on the cluster that has the
largest number of SNPs. The weighted mode-based estimator
weights the number of SNPs within each cluster by the in-
verse variance of each SNP’s effect on the outcome and
returns the casual estimate based on the cluster that has the
largest weighted number of SNPs. The mode-based methods
return an unbiased estimate of the causal effect if the SNPs
within the cluster with the largest number of SNPs (or the
largest weighted number for the weighted model) are all valid
instruments, which is also referred as the ‘ZEMPA assump-
tion (ZEro Model Pleiotropy Assumption)’.
If the five MR models (IVW, MR Egger regression,
weighted median estimator, simple and weighted mode-
based estimator), which make different assumptions re-
garding instrument validity, produce similar estimates of
the causal effect, then we can be more confident in the ro-
bustness of our findings.
Multivariable Mendelian randomization analysis
Two multivariable MR analyses, multivariable IVW re-
gression28 and multivariable MR Egger regression,29 were
performed as additional sensitivity analyses. These multi-
variable approaches take into account the correlation be-
tween the three lipid fractions and the fact that the SNPs
used in the MR analyses using the ‘unrestricted’ SNP set
are often associated with more than one lipid fraction (i.e.
147 and 44 SNPs in our analyses were associated with at
least two lipid fractions with P< 0.05 and 5.0 x 10–8, re-
spectively; Supplementary Table 1, available as
Supplementary data at IJE online).
The multivariable IVW regression was performed by
regressing b^ZYðMatÞ on b^ZX for all three lipid fractions (i.e.
three sets of b^ZX across all 185 SNPs) in a single regression
model. Inverse variance weights of the b^ZYðMatÞ were used
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in the regression model and the intercept was initially fixed
at zero. The multivariable IVW regression analyses were
performed using all 185 SNPs at once with the causal effect
for each exposure estimated from the regression coeffi-
cients for the corresponding set of b^ZX. A critical assump-
tion, additional to the univariate assumptions, for
multivariable MR is that the relationship between genetic
instruments and the outcome is only mediated by the expo-
sures considered in the analysis.28
The multivariable MR Egger regression was performed
also by including all 185 lipid-associated SNPs (i.e. three
sets of b^ZX) in a single regression model. Similar to the uni-
variate MR Egger regression model, the multivariable
model allows the intercept to vary, with a non-zero esti-
mate of the intercept suggestive of horizontal pleiotropy.
We performed three separate analyses. In each of these
analyses the SNP alleles were oriented to reflect the direc-
tion of association at a single lipid fraction (i.e. first HDL-
C, then LDL-C and then triglycerides) to estimate its causal
effect. The advantage of the multivariable MR Egger re-
gression model over the univariate one is that it reduces the
bias when the amount of residual effect on the outcome
(i.e. SNP-outcome associations not via the exposure) is de-
creased by including additional exposures.
We used the TwoSampleMR package30 (version 0.4.11)
in R (version 3.4.3) to perform IVW, MR Egger regression,
weighted median, mode-based estimator and multivariable
IVW MR analyses. We used the codes provided on https://
mrcieu.github.io/TwoSampleMR/ to run the analyses. We
used the R scripts provided in a methods paper30 to per-
form the multivariable Egger regression analysis.
Results
There was little evidence for a causal effect of maternal
gestational concentrations of HDL-C, LDL-C or triglycer-
ides on offspring BW (Figure 3). Each estimate represents
the estimated causal difference in mean SD of offspring
Figure 3.Mendelian randomization estimates of the causal effect of maternal serum high-density lipoprotein cholesterol (HDL-C), low-density lipopro-
tein (LDL-C), and triglyceride concentrations on offspring birth weight. Causal effects are estimated using five univariate MR models [i.e. inverse vari-
ance weighted (IVW), MR Egger regression, weighted median, simple mode-based, and weighted mode-based] and two multivariable MR models
(i.e. multivariable IVW regression and multivariable MR Egger regression). Each univariate MR model was fitted twice using an ‘Unrestricted Set’ of
SNPs (i.e. all SNPs strongly associated with the exposure with P< 5.0 x 10–8) and a ‘Restricted Set’ of SNPs (i.e. SNPs strongly associated with the ex-
posure with P<5.0 x 10–8 but not associated with the other two lipids with P> 0.05). Forest plots show the estimated causal change (b^XY ) in standard
deviations (SD) of offspring birth weight per 1SD higher in serum level of HDL-C, LDL-C or triglycerides with 95% confidence intervals (CIs).
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BW per 1SD higher maternal concentration of HDL-C,
LDL-C or triglycerides. We found no evidence of direc-
tional horizontal pleiotropy at any of the IVs for the three
lipid fractions; the estimates of the intercept of both the
univariate and multivariable MR Egger regressions were
approximately zero in all analyses (Supplementary Table
2, available as Supplementary data at IJE online) and there
was a lack of asymmetry of the funnel plots
(Supplementary Figure 1, available as Supplementary data
at IJE online). We also found little evidence for violation
of the ‘NOME assumption’ for the MR Egger regression as
the I2GX statistics were >97.5% for all analyses (univariate
and multivariable MR regressions for all three lipids;
Supplementary Table 2, available as Supplementary data
at IJE online).
Maternal serum concentrations of HDL-C and off-
spring birth weight
The two-sample MR IVW analysis showed no causal effect
of maternal HDL-C level and offspring weight [SD change
in BW per 1SD higher in HDL-C ¼ 0.005 (0.039,
0.029)]. This was supported by all univariate and multivar-
iable sensitivity analyses (Figures 3 and 4A), and regardless
of whether SNPs from the ‘Unrestricted Set’ or the
‘Restricted Set’ were used in the analysis.
Figure 4. Scatter plots of the estimated SNP effects on offspring birth weight plotted against the estimated SNPs effects on the maternal (A) HDL-C,
(B) LDL-C, and (C) triglyceride concentrations The slopes of the lines are the estimated causal effects of the maternal lipid concentrations on offspring
birth weight, estimated using different MR methods (i.e. inverse variance weighted, MR Egger regression, weighted median, simple mode-based,
and weighted mode-based). An outlier SNP, rs1998013, is labelled in (B). It is distal from all other LDL-C associated SNPs and drives the causal effect
toward the null.
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Maternal serum concentrations of LDL-C and
offspring birth weight
While no causal effect was found in the univariate
IVW analysis [SD change in BW per 1SD higher in
LDL-C¼ 0.014 (0.017, 0.045)], a higher genetically pre-
dicted level of maternal LDL-C tended to be associated with
a higher offspring BW in the weighted median [SD change
in BW per 1SD higher in LDL-C¼ 0.109 (0.020, 0.198)]
and weighted mode-based [SD change in BW per 1SD
higher in LDL-C¼ 0.118 (0.013, 0.222)] analyses using the
‘Restricted Set’ of SNPs (Figures 3 and Supplementary
Figure 2, available as Supplementary data at IJE online).
However, this estimated positive causal effect was not sup-
ported by all other univariate and multivariable analyses.
The SNP rs1998013 appears to be an outlier in the scatter-
plot (Figure 4B). It is distal from all other LDL-C associated
SNPs and it has the largest absolute effect on BW and the
second largest effect on LDL-C that would drive the causal
effect toward the null, which is against the overall effect of
all other SNPs. We excluded it and re-ran the unrestricted
and restricted analyses; the results remained unchanged
(Supplementary Figure 3 and Supplementary Table 3, avail-
able as Supplementary data at IJE online).
Maternal serum concentrations of triglycerides
and offspring birth weight
Similar to the previous two lipid fractions, no causal effect of
maternal triglycerides on offspring BW was detected in the
univariate IVW analysis [SD change in BW per 1SD higher in
triglycerides ¼ 0.014 (0.025, 0.052)], which was supported
by the sensitivity analyses (Figures 3 and 4C).
Discussion
We employed a novel methodological approach to assess
the causal effect of maternal concentrations of LDL-C,
HDL-C and triglycerides on offspring BW using a two-
sample MR framework. The major difference between our
approach and standard two-sample MR is that the SNP-
outcome associations (i.e. SNP-BW associations) have been
partitioned into maternal and fetal genetic components,
which has allowed us to estimate the effect of maternal
exposures on BW, independent of the fetal genetic effects.
We applied this method to examine the causal effect of ma-
ternal gestational LDL-C, HDL-C and triglycerides on off-
spring BW, while controlling for fetal genotype, and found
little support for a causal effect of these on offspring BW.
Results from this study are consistent with our previous
MR study using a smaller sample of genotyped mother–
offspring pairs for HDL-C although we do not find any
evidence of a suggested inverse effect of triglycerides on
birthweight reported in that previous study.6 In that study,
polygenic scores of HDL-C and triglyceride concentrations
were calculated using GWAS summary data on lipid con-
centrations31 and the maternal genotypes, and no associa-
tion was found between genetic scores and offspring BW
after conditioning on offspring genotype, although a sug-
gested effect of triglycerides was noted (albeit with very
wide confidence intervals). The present study has extended
this earlier work by using a much larger sample of individ-
uals and using a range of sensitivity analyses to investigate
possible bias through genetic pleiotropy. We were also able
to explore effects of LDL-C which was not done in that
previous study. As an indication of the power of the novel
two-sample MR approach used here we can compare the
results for the estimated effect of triglycerides on BW from
our two studies. Assuming that the SD for BW is 454 g (the
mean value in the EGG consortium) our result for an effect
of maternal triglycerides on BW is 6.36 g (95%CI: 11.35,
23.61). Compared with our previous study result [33 g
(95%CI: 86, 20)] we now have a more precise estimate
suggesting no evidence of an important effect.
We emphasize that the null associations we found do
not necessarily mean that maternal LDL-C, HDL-C and
triglyceride concentrations have no effect on the develop-
ing fetus. They suggest that these maternal circulating lipid
fraction concentrations have no effect on the overall
growth of the fetus that is reflected by BW. Maternal circu-
lating LDL-C, HDL-C and triglycerides could still impact
the development of a particular organ, growth during a
particular period of pregnancy, or differential growth of
fat, lean and skeletal tissue, but we could not detect these
effects by looking only at BW. Several small detailed stud-
ies have documented how maternal lipid and fatty acid
concentrations change across pregnancy, showing particu-
larly marked increases in triglycerides and more modest
increases in cholesterols and phospholipid concentrations
together with an increase in the proportion of triglycerides
carried in very low-density and low-density lipoprotein
particles towards the end of pregnancy.32 More recently
larger epidemiological studies have shown marked changes
in lipids and lipoproteins as women become pregnant,
which then return to normal after pregnancy.33 Just how
different lipid fractions and fatty acids are carried across
the placenta and are used by the fetus for healthy growth
and development is unclear, but with the emergence of
genome-wide analyses of a much wider range of lipids and
fatty acids34,35 it will be possible to extend the methods
used in this study to determine the impact of more refined
measures of maternal gestational lipid metabolism on BW.
Additionally, BW was obtained from offspring born at full
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term (>37 weeks of gestation), so we are unable to com-
ment on whether these maternal lipid fraction concentra-
tions have an effect on the BW of pre-term offspring.
A key assumption of our study design is that SNPs asso-
ciated with lipid concentrations in the general population
of men and (non-pregnant) women are appropriate instru-
ments for lipid concentrations in mothers during preg-
nancy. Our concern arises from the fact that maternal lipid
concentrations change dramatically during pregnancy,36,37
there may be sex differences in the magnitude of associa-
tion between SNPs and lipid concentrations, and that lipid
concentrations measured at different gestational stages
may have different observational associations with BW.12
We previously showed that maternal gestational HDL-C
and triglycerides were strongly correlated with polygenic
risk scores constructed from HDL-C and triglyceride asso-
ciated SNPs in the general population (although LDL-C
was not examined), suggesting that the same genetic var-
iants proxy lipid concentrations in pregnant and non-
pregnant individuals (see eTable 5 of Tyrrell et al.).6
Larger studies investigating the effect of the lipid-associ-
ated SNPs in pregnant women are required.
Another potential complication in interpreting the
results of these sorts of MR analyses is the extent to which
one can be sure that the causal estimates reflect the effect
of the prenatal environment on the developing offspring.
For example, it is possible that variation in circulating lipid
concentrations before conception might affect oocyte qual-
ity and then have downstream effects on offspring
BW.17,38 It is also possible that the causal estimates could
reflect the effect of postnatal influences on offspring phe-
notype. Although this is unlikely to be a concern for peri-
natal traits like BW where post-natal effects have not had
time to exert appreciable effects on the offspring pheno-
type, it is a potential concern for later life phenotypes, par-
ticularly if the investigator is specifically trying to ascribe a
causal role for the prenatal environment. One way to in-
crease confidence that the MR results do indeed reflect
causal effects of the prenatal environment would be to per-
form similar analyses using paternal genotype (conditional
on offspring genotype). A significant causal relationship
would suggest that the post-natal environment is also likely
to be important in determining the offspring phenotype,
though such a comparison, and indeed our results pre-
sented here, assume that the fetal genotype does not have
an effect on the intrauterine environmental exposure. Fetal
waste products cross the placenta into the maternal circu-
lation and it is possible that fetal genotypes (that are
determined by maternal genotypes for the intrauterine ex-
posure of interest) might influence the secretion of fetal
waste products into the maternal circulation, which in turn
might influence the exposures of interest. Our method, like
two-sample MR in general, is statistically inefficient for ex-
ploring non-linear effects or stratified effects (e.g. by ma-
ternal BMI).
There are no obvious technical reasons why our method
cannot be applied more generally to outcomes other than
BW. The major practical limitation, however, is the avail-
ability of large-scale cohorts with maternal genotypes
along with both maternal and offspring phenotypes so that
unbiased estimates of maternal genetic effects on offspring
outcomes can be made available to researchers for two-
sample MR studies. One way to directly facilitate the avail-
ability of these kinds of data to the scientific community
would be for researchers to publish summary GWAS
results of maternal genotype and offspring phenotype, con-
ditional on offspring genotype. However, performing con-
ditional association analyses across the genome is
computationally intensive, and may be difficult for many
researchers to implement. A more practical alternative
might be for investigators to deposit unconditional GWAS
results of the association between maternal genotype and
offspring phenotype and separate unconditional GWAS
results between offspring genotype and offspring pheno-
type. These summary results could then be used in a struc-
tural equation model to generate unbiased estimates of
maternal and fetal genetic effects on offspring phenotype,
even when the degree of sample overlap is unknown.19
Appropriate standard errors could be obtained in these
models by estimating the degree of sample overlap using
bivariate LD score regression13 and weighting the likeli-
hood appropriately. It is likely that similar results could
also be obtained by using other methods for conditional
GWAS.39–41
Conclusion
Maternal gestational LDL-C, HDL-C and triglyceride con-
centrations do not appear to play a causal role in determin-
ing offspring BW. Our study illustrates how causal
estimates of maternal environmental exposures on off-
spring BW can be generated in extremely large samples of
individuals using a two-sample MR framework, obviating
the requirement for mother–offspring duos with individual
level genotypes. The implication is that the same method
could be used to examine other maternal exposures puta-
tively causally related to offspring BW, and potentially the
relationship between maternal exposures and other off-
spring outcomes once large scale GWAS of maternal effects
are publicly available.
Supplementary data
Supplementary data are available at IJE online.
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